Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03641326
Title Sunitinib in Sarcomas of the Central Nervous System
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

central nervous system sarcoma

gliosarcoma

Therapies

Sunitinib

Age Groups:
Covered Countries USA


No variant requirements are available.